Sign in to view content

Benefits and Value of Treatment for Diabetic Macular Edema

Paul Hahn, MD, PhD, FASRS

Video
Published 2022

Related

A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2018
Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019
Treat-and-Extend Versus Bimonthly Dosing With Aflibercept for the Treatment of Diabetic Macular Edema, 1-Year Outcomes (EVADE Study)
Dilsher S. Dhoot, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more